Cobridge is a regulatory affairs consulting firm that provides comprehensive product-registration services for pharmaceuticals and medical devices in Japan.

Cobridge assists clients in formulating regulatory strategies, in preparing application documents, and in interviews with PMDA and the Ministry of Health, Labor and Welfare.

We also offer a range of regulatory affairs training services to the medical products industry in Japan via a variety of media, including in-house and public seminars.

Cobridge will act on behalf of overseas clients by providing subsidiary functions and related liason services, including that of in-country caretaker for medical products marketed in Japan.

The development of new pharmaceuticals is multifaceted and requires expertise from a variety of pharmaceutical and medical fields.

In order to meet the demands of providing regulatory consulting for clients in the pharmaceutical industry, Cobridge is able to draw upon the expertise of a network of consultants.  This network or corps of consulting resources, The Academy for Pharmaceutical Development, was established by retirees from industry, government and academia, and by current faculty in the pharmaceutical and medical divisions of academic institutions, with the objective of offering the knowledge of professionals with a proven track record of achievement and expertise covering all aspects of pharmaceutical development.  Currently, the Soyaku Academy as it is known in Japan, comprises 50 members, and has a target of 100 members to provide depth as well as breadth of key competencies in this challenging field.  Cobridge is privileged to be able to tap this pool of pharmaceutical expertise in providing consulting services to its clients.